# Jazz Pharmaceuticals, Inc. (JAZZ)

Jazz Pharmaceuticals surges pre-market on positive trial results for Ziihera and a $200M voucher sale, despite a recent earnings miss and competitive pressures.

### About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing medicines.  
Jazz Pharmaceuticals, Inc. uses the ticker $JAZZ for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Jazz Pharmaceuticals, Inc. (JAZZ) social dominance is up 214.29% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) Galaxy Score™ is up 127.78% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) creators is up 51.02% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) mentions is up 44.19% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) posts created is up 57.14% from the previous week.

### Price: $166.30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/close.tsv)  
The stock price is down -1.79% in the last [--] hours due to an earnings miss and increased competition. However, positive trial results for Ziihera and the sale of a Priority Review Voucher for $200M have caused a pre-market surge, suggesting potential upward momentum.  

24-Hour: 0.01%
7-Day: 0.49%
30-Day: -1.83%

1-Year High: $180.90 on 2025-11-24  
1-Year Low: $97.80 on 2025-05-09  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/alt_rank.tsv)  
Jazz Pharmaceuticals, Inc. (JAZZ) is currently AltRank #1,742 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +594  
[--] Month: [-----] +670  
[--] Months: [-----] +931  
[--] Year: [-----] +734  
1-Year High: [-----] on 2026-02-04  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +23  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-02-24  
1-Year Low: [--] on 2026-02-09  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [------]  
[--] Week: [-----] -41%  
[--] Month: [------] -54%  
[--] Months: [----------] +584%  
[--] Year: [----------] +585%  
1-Year High: [----------] on 2025-11-24  
1-Year Low: [---] on 2025-12-28  

Engagements by network (24h):
News: [--]
X: [---]
YouTube: [--]
Reddit: [--]
TikTok: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +44%  
[--] Month: [---] -4.70%  
[--] Months: [-----] -17%  
[--] Year: [-----] +69%  
1-Year High: [---] on 2025-06-17  
1-Year Low: [--] on 2026-01-02  

Mentions by network (24h):
News: [--]
X: [--]
YouTube: [--]
Reddit: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Jazz Pharmaceuticals, Inc. (JAZZ) in the last [--] hours which is up 29% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +51%  
[--] Month: [---] -10%  
[--] Months: [-----] -35%  
[--] Year: [-----] +126%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2026-01-02  
  
  
### Sentiment: 43%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/sentiment.tsv)  
Current Value: 43%  
Daily Average: 80%  
[--] Week: 33% -67%  
[--] Month: 31% -36%  
[--] Months: 31% -47%  
[--] Year: 31% -52%  
1-Year High: 100% on 2025-02-20  
1-Year Low: 31% on 2026-02-15  

Most Supportive Themes:
- Positive Regulatory News and Approvals: (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs. This theme is supported by the recent FDA approval of the Zepzelca-atezolizumab combination.
- Analyst Recommendations and Price Targets: (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity. This is supported by the positive sentiment and high engagement on posts discussing the stock.
- Product Pipeline and Clinical Trials: (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordavipener) and its inclusion in NCCN guidelines. This is supported by the discussions around the company's future prospects.
  
Most Critical Themes:
- Competition and Market Dynamics: (20%) Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share. This is a concern due to the potential impact on Jazz's revenue.
- Earnings Miss and Financial Performance: (10%) The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors. This is reflected in the negative price action.
  
  
  
### Social Dominance: 0.00377%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/social_dominance.tsv)  
Current Value: 0.00377%  
Daily Average: 0.013%  
[--] Week: 0.0022% +0.0015%  
[--] Month: 0.0043% -0.0098%  
[--] Months: 0.0043% -0.0094%  
[--] Year: 0.0043% -0.0089%  
1-Year High: 0.048% on 2025-06-17  
1-Year Low: 0.0022% on 2026-01-02  
  
  
### Market Dominance: 0.011%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/market_dominance.tsv)  
Current Value: 0.011%  
Daily Average: 0%  
1-Year High: 0.034% on 2025-03-31  
1-Year Low: 0.0083% on 2025-08-06  
  
  
### Market Cap: $10,105,846,442
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/market_cap.tsv)  
Current Value: $10,105,846,442  
Daily Average: $8,115,906,998  
[--] Week: $10,105,846,442 +0.49%  
[--] Month: $10,105,846,442 -1.80%  
[--] Months: $10,105,846,442 +40%  
[--] Year: $10,105,846,442 +25%  
1-Year High: $10,992,409,484 on 2025-11-24  
1-Year Low: $6,026,459,193 on 2025-05-09

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing